Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Washington University School of Medicine
City of Hope Medical Center
City of Hope Medical Center
University of Virginia
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
AIDS Malignancy Consortium
Corvus Pharmaceuticals, Inc.
Celgene